| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 14 | 1996 | 110 | 0.820 |
Why?
|
| Amniocentesis | 15 | 1999 | 31 | 0.590 |
Why?
|
| Fetal Diseases | 7 | 1999 | 82 | 0.580 |
Why?
|
| Pregnancy | 41 | 2003 | 3010 | 0.560 |
Why?
|
| Mosaicism | 8 | 1996 | 70 | 0.520 |
Why?
|
| Chorionic Villi Sampling | 10 | 1999 | 13 | 0.480 |
Why?
|
| Trisomy | 7 | 1997 | 55 | 0.410 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2003 | 152 | 0.380 |
Why?
|
| Decision Support Techniques | 5 | 1999 | 167 | 0.370 |
Why?
|
| Chromosome Aberrations | 8 | 1996 | 390 | 0.340 |
Why?
|
| Sex Chromosome Aberrations | 7 | 1991 | 19 | 0.310 |
Why?
|
| Disorders of Sex Development | 4 | 1992 | 18 | 0.290 |
Why?
|
| alpha-Fetoproteins | 3 | 1999 | 43 | 0.260 |
Why?
|
| Fetal Growth Retardation | 3 | 2000 | 67 | 0.240 |
Why?
|
| Y Chromosome | 3 | 1991 | 29 | 0.240 |
Why?
|
| X Chromosome | 3 | 1989 | 153 | 0.220 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2003 | 20 | 0.220 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2003 | 11 | 0.220 |
Why?
|
| Methotrexate | 1 | 2003 | 250 | 0.210 |
Why?
|
| Congenital Abnormalities | 5 | 1998 | 64 | 0.200 |
Why?
|
| Mass Screening | 2 | 2018 | 636 | 0.190 |
Why?
|
| Female | 52 | 2020 | 46014 | 0.190 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 3000 | 0.170 |
Why?
|
| Adult | 33 | 2020 | 26508 | 0.170 |
Why?
|
| Anus, Imperforate | 1 | 1999 | 11 | 0.170 |
Why?
|
| Complementary Therapies | 1 | 2020 | 56 | 0.170 |
Why?
|
| Genetic Diseases, Inborn | 5 | 1998 | 101 | 0.160 |
Why?
|
| Choroid Plexus | 1 | 1997 | 15 | 0.150 |
Why?
|
| Consanguinity | 2 | 1995 | 73 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 1997 | 42 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1987 | 79 | 0.140 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 204 | 0.140 |
Why?
|
| Humans | 58 | 2020 | 89073 | 0.140 |
Why?
|
| Cysts | 1 | 1997 | 106 | 0.140 |
Why?
|
| Genetic Testing | 4 | 1998 | 537 | 0.140 |
Why?
|
| Abnormalities, Multiple | 4 | 1994 | 234 | 0.130 |
Why?
|
| Maternal Age | 7 | 1998 | 45 | 0.130 |
Why?
|
| Choice Behavior | 2 | 1998 | 160 | 0.130 |
Why?
|
| Genetic Counseling | 3 | 1998 | 101 | 0.130 |
Why?
|
| Chromosome Disorders | 6 | 1996 | 115 | 0.120 |
Why?
|
| Karyotyping | 6 | 1997 | 253 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 415 | 0.120 |
Why?
|
| Gastritis, Hypertrophic | 1 | 1993 | 4 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 3443 | 0.120 |
Why?
|
| Chorionic Villi | 3 | 1996 | 11 | 0.110 |
Why?
|
| Infant, Newborn | 9 | 2000 | 2476 | 0.110 |
Why?
|
| Down Syndrome | 1 | 1993 | 55 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1993 | 77 | 0.110 |
Why?
|
| Histocompatibility | 1 | 1993 | 66 | 0.110 |
Why?
|
| Chimera | 1 | 1992 | 56 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 461 | 0.100 |
Why?
|
| HLA Antigens | 4 | 2000 | 227 | 0.100 |
Why?
|
| Amniotic Fluid | 4 | 1996 | 30 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 1991 | 77 | 0.090 |
Why?
|
| Chorion | 1 | 1990 | 14 | 0.090 |
Why?
|
| Ploidies | 1 | 1990 | 41 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1989 | 79 | 0.090 |
Why?
|
| Lymphangioma | 1 | 1989 | 15 | 0.090 |
Why?
|
| Pigment Epithelium of Eye | 2 | 1999 | 13 | 0.080 |
Why?
|
| Genes, MHC Class I | 2 | 2000 | 48 | 0.080 |
Why?
|
| Urinary Tract | 1 | 1989 | 35 | 0.080 |
Why?
|
| Pregnancy, Multiple | 3 | 1983 | 37 | 0.080 |
Why?
|
| Ultrasonography | 6 | 1989 | 711 | 0.080 |
Why?
|
| Abortion, Induced | 3 | 2003 | 131 | 0.080 |
Why?
|
| Turner Syndrome | 1 | 1988 | 27 | 0.080 |
Why?
|
| Urinary Bladder Diseases | 1 | 1988 | 41 | 0.080 |
Why?
|
| Fallopian Tubes | 1 | 2008 | 42 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2000 | 201 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2008 | 81 | 0.080 |
Why?
|
| Hydrops Fetalis | 2 | 2003 | 16 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 1989 | 319 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 229 | 0.070 |
Why?
|
| Abortion, Spontaneous | 4 | 1998 | 66 | 0.070 |
Why?
|
| Genes, BRCA2 | 1 | 2008 | 161 | 0.070 |
Why?
|
| Genes, BRCA1 | 1 | 2008 | 192 | 0.070 |
Why?
|
| Prader-Willi Syndrome | 2 | 1996 | 8 | 0.070 |
Why?
|
| Abortion, Habitual | 2 | 1983 | 33 | 0.070 |
Why?
|
| Metabolism, Inborn Errors | 2 | 1983 | 30 | 0.070 |
Why?
|
| Testicular Hydrocele | 1 | 1984 | 4 | 0.060 |
Why?
|
| Genetic Linkage | 2 | 1983 | 624 | 0.060 |
Why?
|
| Acetylcholinesterase | 1 | 1984 | 47 | 0.060 |
Why?
|
| Parents | 1 | 1988 | 285 | 0.060 |
Why?
|
| Male | 18 | 1998 | 42254 | 0.060 |
Why?
|
| Fibroblasts | 1 | 1988 | 755 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 1999 | 461 | 0.060 |
Why?
|
| Pregnancy, High-Risk | 4 | 1996 | 16 | 0.060 |
Why?
|
| von Willebrand Diseases | 1 | 1983 | 6 | 0.060 |
Why?
|
| Insemination, Artificial, Heterologous | 1 | 1983 | 2 | 0.060 |
Why?
|
| Insemination, Artificial | 1 | 1983 | 16 | 0.060 |
Why?
|
| Uterine Diseases | 1 | 1983 | 19 | 0.060 |
Why?
|
| Klinefelter Syndrome | 1 | 1983 | 5 | 0.060 |
Why?
|
| Leg Ulcer | 1 | 1983 | 7 | 0.060 |
Why?
|
| Mucopolysaccharidosis VII | 1 | 2003 | 1 | 0.050 |
Why?
|
| Coloring Agents | 1 | 1983 | 65 | 0.050 |
Why?
|
| Middle Aged | 8 | 2020 | 25865 | 0.050 |
Why?
|
| Kidney | 2 | 1994 | 1145 | 0.050 |
Why?
|
| Hematologic Diseases | 1 | 1983 | 78 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 3 | 1998 | 20 | 0.050 |
Why?
|
| Leg | 1 | 1983 | 140 | 0.050 |
Why?
|
| Sex Chromosomes | 1 | 1983 | 57 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2003 | 287 | 0.050 |
Why?
|
| Risk Factors | 4 | 1994 | 5466 | 0.050 |
Why?
|
| Biopsy | 2 | 2018 | 1182 | 0.050 |
Why?
|
| Mutation | 2 | 2018 | 4132 | 0.050 |
Why?
|
| Probability | 3 | 1994 | 353 | 0.050 |
Why?
|
| Uterus | 1 | 1983 | 222 | 0.050 |
Why?
|
| Base Sequence | 4 | 1995 | 2327 | 0.050 |
Why?
|
| Genitalia, Female | 2 | 1992 | 25 | 0.050 |
Why?
|
| Physicians | 2 | 1999 | 689 | 0.050 |
Why?
|
| Crohn Disease | 1 | 1987 | 758 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 1995 | 3027 | 0.040 |
Why?
|
| Pedigree | 3 | 1998 | 969 | 0.040 |
Why?
|
| Fetal Death | 3 | 2003 | 57 | 0.040 |
Why?
|
| Time Factors | 3 | 1997 | 5320 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 345 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2000 | 205 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 1996 | 66 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1999 | 11 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2018 | 4273 | 0.040 |
Why?
|
| Health Behavior | 1 | 2020 | 184 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 1999 | 3657 | 0.040 |
Why?
|
| Fetal Viability | 1 | 1998 | 9 | 0.040 |
Why?
|
| Risk | 3 | 1987 | 657 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 1994 | 2014 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 2 | 1996 | 69 | 0.040 |
Why?
|
| Retina | 1 | 1999 | 219 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1996 | 7 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2000 | 254 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1996 | 20 | 0.040 |
Why?
|
| Cell Division | 3 | 1999 | 696 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 2 | 1989 | 10 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 2 | 1989 | 15 | 0.040 |
Why?
|
| Diet | 1 | 2020 | 442 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 322 | 0.030 |
Why?
|
| Cells, Cultured | 6 | 1999 | 2880 | 0.030 |
Why?
|
| Brain Diseases | 1 | 1997 | 185 | 0.030 |
Why?
|
| Aged | 5 | 2020 | 19078 | 0.030 |
Why?
|
| Mucopolysaccharidosis IV | 1 | 1995 | 2 | 0.030 |
Why?
|
| Autoantigens | 1 | 1996 | 129 | 0.030 |
Why?
|
| Intestine, Small | 2 | 1995 | 299 | 0.030 |
Why?
|
| Obstetrics | 1 | 1998 | 123 | 0.030 |
Why?
|
| Genetic Carrier Screening | 2 | 2008 | 60 | 0.030 |
Why?
|
| Syndrome | 2 | 1989 | 449 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 1997 | 202 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 270 | 0.030 |
Why?
|
| Opsonin Proteins | 1 | 1975 | 6 | 0.030 |
Why?
|
| Platelet Adhesiveness | 1 | 1975 | 8 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 1995 | 43 | 0.030 |
Why?
|
| Apolipoproteins B | 2 | 1995 | 35 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 39 | 0.030 |
Why?
|
| Plasma | 1 | 1975 | 51 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 1995 | 186 | 0.030 |
Why?
|
| Mammography | 1 | 2018 | 471 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 1995 | 266 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1975 | 150 | 0.030 |
Why?
|
| Alleles | 2 | 2000 | 1135 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 3 | 1998 | 63 | 0.030 |
Why?
|
| Leukocytes | 1 | 1975 | 204 | 0.030 |
Why?
|
| Steroids | 1 | 1975 | 174 | 0.030 |
Why?
|
| Estriol | 1 | 1993 | 8 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2013 | 63 | 0.030 |
Why?
|
| DNA | 3 | 1998 | 1307 | 0.030 |
Why?
|
| Health Services Research | 1 | 1994 | 137 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1993 | 72 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2013 | 36 | 0.030 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 1993 | 16 | 0.030 |
Why?
|
| Decidua | 1 | 1993 | 19 | 0.030 |
Why?
|
| HLA-DQ Antigens | 1 | 1993 | 51 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 123 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2013 | 98 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 2001 | 0.030 |
Why?
|
| Urethra | 1 | 1994 | 115 | 0.030 |
Why?
|
| Birth Weight | 1 | 1993 | 145 | 0.030 |
Why?
|
| Lymphocytes | 2 | 1996 | 471 | 0.030 |
Why?
|
| Health Policy | 1 | 1994 | 184 | 0.030 |
Why?
|
| Neural Tube Defects | 2 | 1983 | 44 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1995 | 285 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2013 | 264 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 1998 | 599 | 0.030 |
Why?
|
| Anxiety | 1 | 1994 | 308 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1995 | 423 | 0.030 |
Why?
|
| DNA Methylation | 1 | 1996 | 657 | 0.020 |
Why?
|
| Neoplasms | 1 | 1987 | 3035 | 0.020 |
Why?
|
| Cell Line | 3 | 1996 | 2495 | 0.020 |
Why?
|
| Abortion, Therapeutic | 1 | 1991 | 11 | 0.020 |
Why?
|
| Dysgerminoma | 1 | 1990 | 7 | 0.020 |
Why?
|
| Gonads | 1 | 1990 | 19 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1993 | 275 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 661 | 0.020 |
Why?
|
| Decision Trees | 1 | 1991 | 59 | 0.020 |
Why?
|
| Infant | 1 | 1997 | 3147 | 0.020 |
Why?
|
| United States | 3 | 1994 | 6957 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1990 | 103 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1997 | 3717 | 0.020 |
Why?
|
| Adolescent | 3 | 2000 | 9237 | 0.020 |
Why?
|
| Fetal Blood | 1 | 1990 | 93 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 2335 | 0.020 |
Why?
|
| Fetus | 3 | 1996 | 232 | 0.020 |
Why?
|
| HLA-G Antigens | 2 | 2000 | 52 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 1995 | 2011 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 685 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1992 | 1076 | 0.020 |
Why?
|
| Neck | 1 | 1989 | 103 | 0.020 |
Why?
|
| Contrast Media | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1989 | 221 | 0.020 |
Why?
|
| Internationality | 1 | 1988 | 69 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 6289 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1994 | 2863 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 96 | 0.020 |
Why?
|
| Gonadal Dysgenesis | 1 | 1987 | 3 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2000 | 685 | 0.020 |
Why?
|
| Gestational Age | 2 | 2003 | 323 | 0.020 |
Why?
|
| Prevalence | 1 | 1991 | 1240 | 0.020 |
Why?
|
| Biomarkers | 1 | 1993 | 1755 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1993 | 1223 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1988 | 996 | 0.020 |
Why?
|
| Rabbits | 2 | 1999 | 638 | 0.020 |
Why?
|
| Phenotype | 1 | 1992 | 2439 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1984 | 222 | 0.010 |
Why?
|
| Haploidy | 1 | 1983 | 32 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1983 | 39 | 0.010 |
Why?
|
| Mullerian Ducts | 1 | 1983 | 18 | 0.010 |
Why?
|
| Urogenital Abnormalities | 1 | 1983 | 20 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1983 | 145 | 0.010 |
Why?
|
| Tay-Sachs Disease | 1 | 1982 | 6 | 0.010 |
Why?
|
| Fetoscopy | 1 | 1982 | 8 | 0.010 |
Why?
|
| Hemoglobinopathies | 1 | 1982 | 10 | 0.010 |
Why?
|
| Jurisprudence | 1 | 1982 | 25 | 0.010 |
Why?
|
| Computers | 1 | 1983 | 112 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 1982 | 73 | 0.010 |
Why?
|
| Decision Making | 1 | 1988 | 665 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1990 | 1975 | 0.010 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1981 | 14 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1982 | 115 | 0.010 |
Why?
|
| United Kingdom | 1 | 1981 | 164 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 1999 | 2752 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 763 | 0.010 |
Why?
|
| Canada | 1 | 1981 | 208 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 921 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1982 | 173 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1995 | 1796 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 9003 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1999 | 31 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1999 | 67 | 0.010 |
Why?
|
| Keratins | 1 | 1999 | 63 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 73 | 0.010 |
Why?
|
| B7-1 Antigen | 1 | 1999 | 76 | 0.010 |
Why?
|
| Microspheres | 1 | 1999 | 108 | 0.010 |
Why?
|
| Liver | 2 | 1995 | 1205 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 51 | 0.010 |
Why?
|
| Human Genome Project | 1 | 1998 | 19 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1999 | 90 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 370 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1998 | 306 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 1998 | 52 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 245 | 0.010 |
Why?
|
| snRNP Core Proteins | 1 | 1996 | 9 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 543 | 0.010 |
Why?
|
| Placenta | 1 | 1998 | 179 | 0.010 |
Why?
|
| Attitude to Health | 1 | 1998 | 222 | 0.010 |
Why?
|
| CpG Islands | 1 | 1996 | 157 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1983 | 1371 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1999 | 491 | 0.010 |
Why?
|
| APOBEC-1 Deaminase | 1 | 1995 | 2 | 0.010 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 1995 | 4 | 0.010 |
Why?
|
| Coenzyme A Ligases | 1 | 1995 | 8 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1996 | 147 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1995 | 41 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 27 | 0.010 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1975 | 6 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1998 | 582 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1998 | 307 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1975 | 44 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1975 | 42 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1997 | 684 | 0.010 |
Why?
|
| Prednisone | 1 | 1975 | 258 | 0.010 |
Why?
|
| Models, Psychological | 1 | 1994 | 158 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1975 | 302 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1999 | 1067 | 0.010 |
Why?
|
| CD3 Complex | 1 | 1993 | 134 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1993 | 223 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 1239 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1975 | 249 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 1998 | 625 | 0.010 |
Why?
|
| Catheterization | 1 | 1993 | 237 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1975 | 948 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 156 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1999 | 2612 | 0.010 |
Why?
|
| Plasmids | 1 | 1990 | 291 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1993 | 306 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1990 | 272 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1993 | 445 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1990 | 111 | 0.010 |
Why?
|
| Animals | 2 | 1999 | 27324 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 1401 | 0.000 |
Why?
|
| Child | 1 | 1995 | 7149 | 0.000 |
Why?
|
| Metaphase | 1 | 1982 | 25 | 0.000 |
Why?
|
| Chromosome Banding | 1 | 1982 | 74 | 0.000 |
Why?
|